White Paper
Most Common Reasons for FDA Form 483 Observations and Warning Letters in Medical Device Environments
Loading Content
About this Document
This industry brief addresses the common issues that result in observations and warnings from the U.S. Food and Drug Administration. The information is based on data compiled between 2017 and 2019. It also provides insight on how companies can use MasterControl solutions to more easily identify and mitigate issues.
PDF
— 1.67MB
